DISCOUNT-ZERTIFIKAT - AMGEN | Market Closed - Deutsche Boerse AG 11:02:54 27/05/2024 pm IST | ||
| 220 EUR | -0.06% |
|
| Current month | -0.71% | ||
| 1 month | -0.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 220 | -0.06% |
| 24/24/24 | 220.1 | -0.28% |
| 23/24/23 | 220.8 | +0.21% |
| 22/24/22 | 220.3 | +0.14% |
| 21/24/21 | 220 | +0.11% |
Delayed Quote Deutsche Boerse AG
Last update May 27, 2024 at 11:02 pm IST
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Citi
|
| WKN | KH22W1 |
| ISIN | DE000KH22W15 |
| Date issued | 31/01/2023 |
| Maturity | 20/06/2024 (24 Days) |
| Parity | 1 : 1 |
| Emission price | 190.1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 222.2 € |
|---|---|
| Lowest since issue | 181.7 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
